Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,61476,Aia3,Adjuvant induced arthritis QTL 3,3.9,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,86532519,131532519,Rat,n/a,region,qtl 1000,738031,Alc14,Alcohol consumption QTL 14,7.6,0.00003,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,58640017,154427984,Rat,n/a,region,qtl 1000,738016,Alc16,Alcohol consumption QTL 16,3.6,0.00015,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,58640017,154427984,Rat,n/a,region,qtl 1000,70200,Alc18,Alcohol consumption QTL 18,9.2,,drinking behavior trait (VT:0001422),ethanol intake volume to total fluid intake volume ratio (CMO:0001591),4,55324953,148360954,Rat,n/a,region,qtl 1000,1641833,Alc21,Alcohol consumption QTL 21,8.6,0.0001,drinking behavior trait (VT:0001422),ethanol drink intake rate (CMO:0001407),4,55375865,125671711,Rat,n/a,region,qtl 1000,1641919,Alc22,Alcohol consumption QTL 22,,0.0005,drinking behavior trait (VT:0001422),ethanol drink intake rate (CMO:0001407),4,62947687,125671711,Rat,n/a,region,qtl 1000,634335,Anxrr16,Anxiety related response QTL 16,7.22,,locomotor behavior trait (VT:0001392),number of entries into a discrete space in an experimental apparatus (CMO:0000960),4,94893247,168046938,Rat,n/a,region,qtl 1000,6478760,Anxrr45,Anxiety related response QTL 45,,0.06717,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,110702761,155702761,Rat,n/a,region,qtl 1000,6478763,Anxrr46,Anxiety related response QTL 46,,0.07428,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,110702761,155702761,Rat,n/a,region,qtl 1000,12798519,Anxrr54,Anxiety related response QTL 54,2.54,0.05,locomotor behavior trait (VT:0001392),"distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)",4,112807675,157807675,Rat,n/a,region,qtl 1000,12798523,Anxrr56,Anxiety related response QTL 56,2.83,0.05,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,86312589,147702403,Rat,n/a,region,qtl 1000,724522,Bp146,Blood pressure QTL 146,2.2,0.0021,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,75258970,120258970,Rat,n/a,region,qtl 1000,2303168,Bp330,Blood pressure QTL 330,4.25,0.017,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,3043231,145254791,Rat,n/a,region,qtl 1000,2306899,Bp338,Blood pressure QTL 338,,0.071,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,81874073,119546974,Rat,n/a,region,qtl 1000,10755501,Bp390,Blood pressure QTL 390,2.5,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),4,23850384,169318094,Rat,n/a,region,qtl 1000,7207480,Bss105,Bone structure and strength QTL 105,8.1,,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),4,109636356,154636356,Rat,n/a,region,qtl 1000,1578670,Bss14,Bone structure and strength QTL 14,16.4,,femur morphology trait (VT:0000559),bone trabecular cross-sectional area (CMO:0002311),4,87136446,132136446,Rat,n/a,region,qtl 1000,1578662,Bss15,Bone structure and strength QTL 15,19.6,,femur width (VT:1000666),femoral neck width (CMO:0001695),4,87136446,132136446,Rat,n/a,region,qtl 1000,1549832,Bss3,Bone structure and strength QTL 3,11,,femur morphology trait (VT:0000559),femur midshaft cortical cross-sectional area (CMO:0001663),4,109636356,154636356,Rat,n/a,region,qtl 1000,61434,Cia3,Collagen induced arthritis QTL 3,4.8,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,99066823,144066823,Rat,n/a,region,qtl 1000,61330,Eau1,Experimental allergic uveoretinitis QTL 1,,0.0003,uvea integrity trait (VT:0010551),experimental autoimmune uveitis score (CMO:0001504),4,70773471,132455556,Rat,n/a,region,qtl 1000,1576305,Emca6,Estrogen-induced mammary cancer QTL 6,5.8,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),4,43414605,155469929,Rat,n/a,region,qtl 1000,1576316,Ept5,Estrogen-induced pituitary tumorigenesis QTL 5,3.8,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),4,84475257,178931073,Rat,n/a,region,qtl 1000,1354612,Foco1,Food consumption QTL 1,8.87,,eating behavior trait (VT:0001431),food intake rate (CMO:0000427),4,43414792,146942075,Rat,n/a,region,qtl 1000,2312567,Glom19,Glomerulus QTL 19,1.9,0.006,kidney glomerulus morphology trait (VT:0005325),index of glomerular damage (CMO:0001135),4,49906054,145611886,Rat,n/a,region,qtl 1000,1358202,Gluco11,Glucose level QTL 11,2.4,0.02,adipocyte glucose uptake trait (VT:0004185),absolute change in adipocyte glucose uptake (CMO:0000873),4,86438317,168047091,Rat,n/a,region,qtl 1000,1582232,Gluco25,Glucose level QTL 25,3.6,0.0023,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,86312589,146942261,Rat,n/a,region,qtl 1000,2316958,Gluco58,Glucose level QTL 58,10,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,7850904,182171018,Rat,n/a,region,qtl 1000,631662,Hcar2,Hepatocarcinoma resistance QTL 2,3.1,0.0003,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),4,79555067,124555067,Rat,n/a,region,qtl 1000,737821,Hcar9,Hepatocarcinoma resistance QTL 9,3.7,,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),4,105971071,168047091,Rat,n/a,region,qtl 1000,1331759,Hrtrt13,Heart rate QTL 13,3.54628,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),4,108876717,169215811,Rat,n/a,region,qtl 1000,1300116,Hrtrt5,Heart rate QTL 5,3.76,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),4,115372758,150038284,Rat,n/a,region,qtl 1000,631674,Iddm14,Insulin dependent diabetes mellitus QTL 14,,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),4,63537179,157286626,Rat,n/a,region,qtl 1000,2302051,Pia28,Pristane induced arthritis QTL 28,5.3,0.001,blood autoantibody amount (VT:0003725),serum immunoglobulin G-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002112),4,75258970,120258970,Rat,n/a,region,qtl 1000,2302049,Pia32,Pristane induced arthritis QTL 32,5.1,0.001,blood autoantibody amount (VT:0003725),serum immunoglobulin G-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002112),4,105277348,150277348,Rat,n/a,region,qtl 1000,61418,Pia5,Pristane induced arthritis QTL 5,4.5,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,61038901,127777403,Rat,n/a,region,qtl 1000,738015,Pia9,Pristane induced arthritis QTL 9,4.5,0.048,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,76567036,121567036,Rat,n/a,region,qtl 1000,738009,Sach4,Saccharine consumption QTL 4,4.9,0.000016,consumption behavior trait (VT:0002069),saccharin intake volume to total fluid intake volume ratio (CMO:0001601),4,58640017,154427984,Rat,n/a,region,qtl 1000,1354660,Salc1,Saline consumption QTL 1,11.26,,drinking behavior trait (VT:0001422),saline drink intake rate (CMO:0001627),4,43414792,146942075,Rat,n/a,region,qtl 1000,631689,Scl4,Serum cholesterol level QTL 4,1.9,0.008,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),4,94414208,139414208,Rat,n/a,region,qtl 1000,61406,Scwia1,Streptococcal cell wall induced arthritis QTL 1,2.3,,joint integrity trait (VT:0010548),experimental arthritis severity measurement (CMO:0001459),4,105682594,150682594,Rat,n/a,region,qtl 1000,1358352,Srcrt3,Stress Responsive Cort QTL 3,2.29,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,36615599,145611886,Rat,n/a,region,qtl 1000,1331802,Srn5,Serum renin concentration QTL 5,3.045,,renin activity (VT:0005581),plasma renin activity level (CMO:0000116),4,116726724,157291438,Rat,n/a,region,qtl 1000,631646,Stl4,Serum triglyceride level QTL 4,6.5,0.0001,blood triglyceride amount (VT:0002644),plasma triglyceride level (CMO:0000548),4,73786419,132455556,Rat,n/a,region,qtl 1000,1298082,Stresp4,Stress response QTL 4,,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,46898276,145611886,Rat,n/a,region,qtl 1000,731165,Uae21,Urinary albumin excretion QTL 21,2.4,0.0001,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),4,106347236,151347236,Rat,n/a,region,qtl 1000,70177,Xhs1,X-ray hypersensitivity QTL 1,25.1,,intestine integrity trait (VT:0010554),post-insult time to onset of moribundity (CMO:0001896),4,81959983,152055009,Rat,n/a,region,qtl 1000,634334,Xhs3,X-ray hypersensitivity QTL 3,10,,intestine integrity trait (VT:0010554),post-insult time to onset of moribundity (CMO:0001896),4,85794049,129615056,Rat,n/a,region,qtl